SCHEMBL7705877

SCHEMBL7705877

COc1csc(-c2nc3cc(-c4ccccc4)cc(N)n3n2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.41
ALDH1A1 P00352 5/20 0.41
NPC1 O15118 5/20 0.41
RAB9A P51151 5/20 0.41
HPGD P15428 3/20 0.41
NFKB1 P19838 1/20 0.41
HTT P42858 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
KMT2A Q03164 3/20 0.41
STAT3 P40763 1/20 0.41
KDM4E B2RXH2 3/20 0.41
PKM P14618 1/20 0.41
CDK5 Q00535 1/20 0.41
CDK5R1 Q15078 1/20 0.41
MEN1 O00255 2/20 0.39
GAA P10253 1/20 0.39
ADORA2A P29274 2/20 0.37
MAPT P10636 2/20 0.37
STAT1 P42224 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7711838 0.92 SMN1; SMN2 (0.50) SMN1; SMN2ALDH1A1NPC1RAB9AHPGD
SCHEMBL7711818 0.89 ALDH1A1 (0.42) SMN1; SMN2ALDH1A1NPC1RAB9AHPGD
SCHEMBL7708546 0.89 NPC1 (0.42) SMN1; SMN2ALDH1A1NPC1RAB9AHPGD
SCHEMBL7708772 0.88 SMN1; SMN2 (0.38) SMN1; SMN2ALDH1A1NPC1RAB9AHPGD
SCHEMBL7705875 0.83 TP53 (0.42) SMN1; SMN2ALDH1A1NPC1RAB9AHPGD
SCHEMBL7709149 0.83 FYN (0.46) MAPT
SCHEMBL7708784 0.82 SMN1; SMN2 (0.54) SMN1; SMN2ALDH1A1NPC1RAB9AHPGD
SCHEMBL7433615 0.81 KDM4E (0.39) SMN1; SMN2ALDH1A1NPC1RAB9AHPGD
SCHEMBL7709218 0.81 ALDH1A1 (0.45) SMN1; SMN2ALDH1A1NPC1RAB9AHPGD
SCHEMBL7703244 0.79 DPP4 (0.47) SMN1; SMN2ALDH1A1NPC1RAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6355653-B1 DRUG AND CARRIER FOR ANTIALLERGENS, BRAIN DISORDERS AND NEUROTRANSMITTERS HOFFMANN-LA ROCHE INC. 2002-03-12 US disclosed